Page 1372 - Problem-Based Feline Medicine

1364 DRUG INDEX 3

Frequency (h) b 24 h 4 days/wk 24 (avoid extravasation) dose based on 12 (adjust monitoring) 12 12 24 12–24 once a wk 4 days then 24h for 1–5 days 24 for 2x wk 72 or 2 wk 72 or 5 days, every 21 24 for days 6–8 h, every 21 over days 3–5 days; wait 24 for wks weekly 24 12 4–6 wks 12 for 8 2 doses then, 8 h 2 h for day for

infusion

IV liquid (15 mg/ml)
Route a PO 4 hour PO PO drop in eye PO PO IV, IM, SC IV, IM, SC Intrathecal PO IV drip IV IV IV SC PO PO PO IV, IM, SC

6.25–12.5 mg/cat 1–2% solution 0.5–1 mg/kg 30–50 mg/kg 1.5–3.3 mg/kg 200–250 mg/m 2 1000 mg/m 2 0.015 mg/kg 0.7–1.5 mg/m 2 5–10 mg/kg 0.7–1 mg/kg

Dose 4–6 mg/kg 3–7 mg/kg 10 mg/kg 2–4 mg/cat 100 mg/m 2 20 mg/m 2 0.22 ml/kg 70 IU/kg 1.1 mg/kg 10 mg/kg

immunosuppressive therapy pigmentary keratitis plasmoma neoplasms bite

and Immune thrombocytopenia, SLE, sebaceous adenitis Keratoconjunctivitis sicca, prevention tissue sarcomas Immune-mediated disorders Brown recluse spider
Indications Anticancer of third eyelid Diuretic Appetite stimulant Anticancer Tick Lymphoreticular Soft Anticancer DIC, thrombosis heparin) Mycobacteriosis Iron chelator

Continued Drug Cyclosporine Cyclosporine ophthalmic Cyclothiazide Cyproheptidine Cytarabine Cythioate Dacarbazine Dactinomycin Dalteparin (LMW Danazolol Dapsone Deferoxamine mesylate